Últimos Artículos de Lancet Diabetes & Endocrinology
- [Correspondence] Evaluation of a type 2 diabetes remission programme
- [Correspondence] Evaluation of a type 2 diabetes remission programme – Authors' reply
- [Correspondence] Evaluation of a type 2 diabetes remission programme
- [Editorial] The era of GLP-1 receptor agonists: costs versus benefits
- [Comment] The impact of the US election on diabetes
- [Correspondence] Dysglycaemia definitions and progression to clinical type 1 diabetes in children with multiple islet autoantibodies
- [Articles] Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013–22): a longitudinal analysis of data from paediatric diabetes registries
- [Comment] Achievement of HbA1c targets: real-world data from international paediatric type 1 diabetes registries
- [Personal View] Time to reframe the disease staging system for type 1 diabetes
- [Correspondence] Medications for obesity as preventatives: a public and patient safety issue
- [Corrections] Correction to Lancet Diabetes Endocrinol 2024; published online Nov 12. https://doi.org/10.1016/S2213-8587(24)00283-3
- [Articles] Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
- [Comment] The promise and hope of GLP-1 receptor agonists
- [Articles] Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial
- [Comment] One step closer to the end of postoperative radioactive iodine thyroid remnant ablation
- [Editorial] Putting wellbeing at the core of diabetes care
- [Articles] Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
- [Comment] Setmelanotide for the treatment of severe early-childhood genetic obesity
- [Review] Hypothalamic obesity: from basic mechanisms to clinical perspectives
- [Articles] Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium